New Zealand Could Save $96M by Ending Airport Tobacco Sales

New Zealand once led the world in reducing smoking rates, but there's a glaring gap in its strategy. While the country raised tobacco taxes annually to discourage smoking, airports and duty-free stores still sell cigarettes at a fraction of normal prices.

The contradiction is costing lives and money. Between 2015 and 2024, these discounted tobacco sales cost New Zealand's government between $60 million and $96 million in lost tax revenue, according to new research from health policy experts.

The numbers tell a story of missed opportunities. That $60 million could have funded around 600 Keytruda treatments for early-stage breast cancer patients who currently have to pay out of pocket. It could have provided 2,000 hip or knee replacement surgeries, or significantly boosted mental health services.

The policy worked everywhere else. From 2011 to 2020, New Zealand increased tobacco taxes by 10% annually, which helped drive down smoking rates dramatically. Research consistently shows that every 10% price increase reduces tobacco consumption by about 5%.

In 2014, the government recognized the problem and reduced the duty-free allowance from 200 cigarettes to 50. Sales dropped sharply the following year, but the revenue gap remains.

The science behind tobacco taxes is clear. Higher prices reduce smoking overall, help more people quit, and prevent young people from starting. The policy particularly helps people on lower incomes and young people, who are more sensitive to price increases.

The Ripple Effect

Ending duty-free tobacco sales would do more than fill budget holes. It would align New Zealand's actions with its commitments as a member of the World Health Organization's Framework Convention on Tobacco Control. The WHO has specifically recommended that member countries either end duty-free tobacco sales or apply full taxes to them.

The health system stands to gain in multiple ways. Fewer people smoking means lower rates of cancer and cardiovascular disease over time. The immediate revenue could address critical gaps in care, from cancer treatments to joint replacements that improve quality of life for thousands.

New Zealand has an explicit goal of becoming smoke-free by 2025 and eliminating smoking-related health inequities, particularly for Māori and Pacific peoples. Duty-free tobacco sales directly contradict these ambitions.

The solution is straightforward. Applying standard excise and GST taxes to duty-free tobacco products would generate immediate revenue while reinforcing the proven effectiveness of price-based tobacco control. Unlike perfume or chocolate, tobacco kills two out of three long-term users and remains a leading cause of preventable death.

Other countries are watching. By closing this loophole, New Zealand could reclaim its leadership role in tobacco control and inspire similar action globally, turning a policy gap into a model for protecting public health while strengthening healthcare funding.